
After Vishwajit Rane announced using the anti-parasitic drug Ivermectin as a "prophylaxis treatment," WHO warned against using the drug for COVID-19.
In a series of tweets, Rane stated that the government's decision was based on "expert panels from the U.K., Italy, Spain, and Japan." The panel allegedly found that Ivermectin reduced mortality from COVID-19 as well as the time to recovery in COVID-19 patients. Therefore, the treatment could help reduce the severity of the virus.
Soumya Swaminathan, the Chief Scientist at WHO, warned against using Ivermectin for COVID-19, "except within clinical trials." Similarly, Merck, a German healthcare company and Ivermectin's manufacturer, stated that there was "no scientific basis for a potential therapeutic effect against COVID-19" from Ivermectin's clinical studies.
Other countries, including the U.S., do not approve of using the anti-parasitic drug for COVID-19 in patients.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19, including symptoms, prevention, and available treatment, please refer to the World Health Organisation or your national healthcare authority.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19, including symptoms, prevention, and available treatment, please refer to the World Health Organization or your national healthcare authority.
Copied!